About Greybrook

Real Estate Investors & Value Creators

Greybrook actively invests equity on behalf of individual and institutional investors in large-scale real estate developments. Playing an active management role, we collaborate alongside our roster of top-tier execution partners to drive results. Our growing North American real estate investment portfolio includes more than 60 million square feet of projected density with an estimated completion value of $30 billion and includes notably, the Waldorf Astoria Hotel & Residences Miami, 138 Yorkville – ultra-luxury residences, and our Society Living platform, an innovative approach to purpose-built Class A multi-family.

Pioneering Advancements in Human Health

Our management team has built a reputation for identifying business opportunities that reside at the forefront of change and the advancement of human health (more on Greybrook Health). Through an exclusively principal investment strategy, Greybrook has made notable investments in Greenbrook TMS (NASDAQ: GBNH, TSX: GTMS), a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders founded by Greybrook with over 125 clinics across the U.S., and Delos, the pioneer and global authority on the health and wellness of humans in the places where we live, eat, sleep and play, and the founder of the International WELL Building Institute and WELL Building Standard.